US-based Moderna, Inc. has announced that the Therapeutic Goods Administration (TGA) has granted provisional registration to its COVID-19 Vaccine in Australia for active immunization to prevent COVID-19 in individuals 18 years of age and older.

Delivery of Moderna’s COVID-19 vaccine to Australia is expected to commence in the second half of September.

The Australian government has previously secured 10 million doses of Moderna COVID-19 Vaccine for delivery in 2021, through a supply agreement announced on May 12, 2021, as well as an option to procure 15 million doses in 2022.

Moderna has also received emergency (or other conditional, interim or provisional) authorization for use of its COVID-19 vaccine from health agencies in more than 50 countries and an Emergency Use Listing (EUL) from the World Health Organization (WHO).

The TGA continues to evaluate an application for provisional registration of Moderna’s COVID-19 vaccine for use in adolescents aged 12 to 18 years.